However, loss of TIMP1 and associated loss of PTEN promoted invasion and migration in prostate cancer in vivo [85], while TIMP1 overexpression was associated with cancer progression and poor prognosis in numerous clinical studies [86,87]. Here, TIMP1 is linked to prostate cancer.